Stockscreener 앱 받기
1.29
0.77%
-0.01
시간 외 거래:
1.29
전일 마감가:
$1.30
열려 있는:
$1.32
하루 거래량:
44,707
Relative Volume:
1.22
시가총액:
$36.78M
수익:
-
순이익/손실:
$-61.28M
주가수익비율:
-0.5119
EPS:
-2.52
순현금흐름:
$-46.46M
1주 성능:
-3.73%
1개월 성능:
-3.73%
6개월 성능:
-22.75%
1년 성능:
+4.88%
1일 변동 폭
$1.28
$1.33
1주일 범위
$1.28
$1.40
52주 변동 폭
$1.03
$2.57
Nextcure Inc Stock (NXTC) Company Profile
명칭
Nextcure Inc
전화
240-399-4900
주소
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
NXTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| NXTC | 1.29 | 36.78M | 0 | -61.28M | -46.46M | -2.52 |
| VRTX | 450.37 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.74 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Nextcure Inc Stock (NXTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-11-04 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2022-03-01 | 개시 | Ladenburg Thalmann | Buy |
| 2021-03-05 | 업그레이드 | Truist | Hold → Buy |
| 2021-01-15 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-07-16 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-07-13 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2020-07-13 | 다운그레이드 | SunTrust | Buy → Hold |
| 2020-06-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2020-06-01 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-05-26 | 개시 | JMP Securities | Mkt Outperform |
| 2020-03-24 | 개시 | The Benchmark Company | Buy |
| 2020-03-02 | 개시 | ROTH Capital | Buy |
| 2020-01-13 | 개시 | SunTrust | Buy |
| 2019-12-05 | 개시 | Needham | Buy |
| 2019-11-26 | 개시 | BTIG Research | Buy |
| 2019-07-09 | 개시 | BofA/Merrill | Buy |
| 2019-06-03 | 개시 | Morgan Stanley | Overweight |
| 2019-06-03 | 개시 | Piper Jaffray | Overweight |
모두보기
Nextcure Inc 주식(NXTC)의 최신 뉴스
Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta - The Manila Times
NextCure's NC605 Shows 90% Fracture Prevention in Breakthrough Bone Disease Study | NXTC Stock News - StockTitan
Logos Global Management LP Reduces Stake in NextCure Inc - GuruFocus.com
Affinity Asset Advisors, LLC Increases Stake in NextCure Inc - GuruFocus.com
Here's Why We're Watching NextCure's (NASDAQ:NXTC) Cash Burn Situation - Simply Wall St
NextCure Reports Improved Financial Performance and Strategic Focus - TipRanks
National Presto Industries, Inc. (NYSE:NPK) Shares Sold by State of Alaska Department of Revenue - Defense World
NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results - The Manila Times
NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual Meeting - The Manila Times
NextCure Reports Preclinical Data for LNCB74 and Additional Clin - WICZ
NextCure (NASDAQ:NXTC) Shares Down 3.6% – Here’s Why - Defense World
NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting - The Manila Times
Elevation Capital Advisory LLC Purchases New Shares in Vanguard Information Technology ETF (NYSEARCA:VGT) - americanbankingnews.com
Affinity Asset Advisors LLC Invests $432,000 in NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) - Defense World
NextCure, Inc. (NASDAQ:NXTC) Shares Purchased by Logos Global Management LP - Defense World
Next plc Executes Share Buyback Program - TipRanks
Nexteq PLC Announces Share Buyback and Voting Rights Update - TipRanks
Next PLC Executes Share Buy-Back for Cancellation - TipRanks
Next plc Conducts Share Buyback and Cancellation - TipRanks
Next lifts profit guidance to almost £1bn - Investors Chronicle
Next PLC’s Fresh Guidance Lift, Overseas Plans Boost Shares - The Wall Street Journal
Next PLC Impresses Investors with Yet Another Guidance Upgrade - TipRanks
Next is approaching a historic profit landmark- what is driving this growth? - Proactive Investors Australia
Next Shares Rise 3% As Full-Year Estimates Hiked - Forbes
Next shares rise on upbeat full-year profit outlook By Investing.com - Investing.com South Africa
Record high for Next shares after guidance raised again - Interactive Investor
Next Lifts Profit Target Again as Autumn Fashion Sales Surge - BNN Bloomberg
UK's Next raises forecast to put 1 billion pound profit in sight - Reuters
Britain's Next on track for 1 billion pounds annual profit - Marketscreener.com
Next Raises FY Pre-Tax Profit Guidance By £15 Mln - XM
NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024 - ForexTV.com
Is NextCure (NASDAQ:NXTC) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Assenagon Asset Management S.A. Sells 864 Shares of Stantec Inc. (NYSE:STN) - Defense World
Assenagon Asset Management S.A. Buys 131 Shares of Watsco, Inc. (NYSE:WSO) - Defense World
Assenagon Asset Management S.A. Sells 473,491 Shares of U.S. Silica Holdings, Inc. (NYSE:SLCA) - Defense World
Vanguard Group Inc. Raises Stock Holdings in NextCure, Inc. (NASDAQ:NXTC) - Defense World
NextCure (NASDAQ:NXTC) Stock Rating Reaffirmed by Needham & Company LLC - Defense World
NextCure, Inc. (NASDAQ:NXTC) Sees Significant Drop in Short Interest - Defense World
NextCure (NASDAQ:NXTC) Trading Down 3.6% - Defense World
We're Keeping An Eye On NextCure's (NASDAQ:NXTC) Cash Burn Rate - Simply Wall St
Advanced Gastric Carcinoma Pipeline 2024 | Jiangsu Hengrui - openPR
NextCure to Present at the H.C. Wainwright 25th Annual Global Investment Conference - Quantisnow
NextCure to Present at 22nd Annual Needham Virtual Healthcare Conference - Quantisnow
NextCure to Present at the JMP Securities Life Sciences Conference - Quantisnow
NextCure to Present at 11th Annual SVB Leerink Global Healthcare Conference - Quantisnow
NextCure and LegoChem Biosciences Enter into Collaboration and Co-Development Agreement to Develop Antibody ... - Quantisnow
NextCure to Present Trial in Progress Poster for NC525 at the 2022 American Society of Hematology (ASH) Annual ... - Quantisnow
NextCure to Present at the Ladenburg Thalmann Healthcare Conference - Quantisnow
NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference - Quantisnow
What Type Of Shareholders Own The Most Number of NextCure, Inc. (NASDAQ:NXTC) Shares? - Yahoo Movies Canada
NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - ForexTV.com
Nextcure Inc (NXTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
3.56%
자본화:
|
볼륨(24시간):